ACTIVITY OF AMPHIPATHIC POLY(ETHYLENE GLYCOL)-5000 TO PROLONG THE CIRCULATION TIME OF LIPOSOMES DEPENDS ON THE LIPOSOME SIZE AND IS UNFAVORABLE FOR IMMUNOLIPOSOME BINDING TO TARGET

被引:406
作者
KLIBANOV, AL
MARUYAMA, K
BECKERLEG, AM
TORCHILIN, VP
HUANG, L
机构
[1] UNIV TENNESSEE,DEPT BIOCHEM,KNOXVILLE,TN 37996
[2] MOSCOW EXPTL CARDIOL INST,DEPT ENZYME ENGN,MOSCOW,USSR
关键词
LIPOSOME; CIRCULATION TIME; POLY(ETHYLENE GLYCOL); TARGETED DRUG DELIVERY; DRUG TARGETING; GANGLIOSIDE;
D O I
10.1016/0005-2736(91)90385-L
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dioleoyl-N-(monomethoxy polyethyleneglycol succinyl)-phosphatidylethanolamine (PEG-PE) (mol. wt. of PEG = 5000), an amphipathic polymer, can be incorporated into the liposome membrane and significantly prolong the blood circulation time of the liposome. As little as 3.7 mol% of PEG-PE in liposome resulted in maximal enhancement of liposome circulation time. However, this activity of PEG-PE was only seen with relatively small liposomes (d less-than-or-equal-to 200 nm); larger liposomes containing PEG-PE showed an unusually high level (approx. 35% injected dose) of accumulation in the spleen. We have tested whether the small, PEG-PE containing liposomes are suitable for immuno targeting by incorporating a lung-specific monoclonal antibody on the liposome surface. While another amphiphile, ganglioside GM1, which is well known for its activity to prolong the liposome circulation time, significantly enhanced the lung binding of the immunoliposomes, PEG-PE incorporation of immunoliposomes resulted in a low level of target binding. To test if the reduced target binding is due to a steric barrier effect of the surface PEG polymer, we have incorporated a small amount of N-biotinaminocaproylphosphatidylethanolamine into the PEG-PE containing liposomes and examined the liposome agglutination induced by the addition of streptavidin. As little as 0.72 mol% PEG-PE in these liposomes completely abolished agglutination. In contrast, incorporation of GM1 in liposomes only reduced the rate, but not the extent, of liposome agglutination. These results strongly support the hypothesis that PEG-PE prolongs liposome circulation time by providing a strong steric barrier which prevents close contact with another liposome or cell. Since GM1 provides only a weak steric barrier effect, its activity to prolong the liposome circulation time must involve another yet unknown mechanism.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 18 条
[1]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[2]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[3]  
ALLENT M, 1988, P NATL ACAD SCI USA, V85, P8067
[4]   MODE OF LIPOSOME-CELL INTERACTIONS BIOTIN-CONJUGATED LIPIDS AS ULTRASTRUCTURAL PROBES [J].
BAYER, EA ;
RIVNAY, B ;
SKUTELSKY, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 550 (03) :464-473
[5]   LIPOSOME FORMULATIONS WITH PROLONGED CIRCULATION TIME IN BLOOD AND ENHANCED UPTAKE BY TUMORS [J].
GABIZON, A ;
PAPAHADJOPOULOS, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6949-6953
[6]   IODOACETYLATED AND BIOTINYLATED LIPOSOMES - EFFECT OF SPACER LENGTH ON SULFHYDRYL LIGAND-BINDING AND AVIDIN PRECIPITABILITY [J].
HASHIMOTO, K ;
LOADER, JE ;
KINSKY, SC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 856 (03) :556-565
[7]   HIGHLY EFFICIENT IMMUNOLIPOSOMES PREPARED WITH A METHOD WHICH IS COMPATIBLE WITH VARIOUS LIPID COMPOSITIONS [J].
HOLMBERG, E ;
MARUYAMA, K ;
LITZINGER, DC ;
WRIGHT, S ;
DAVIS, M ;
KABALKA, GW ;
KENNEL, SJ ;
HUANG, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1272-1278
[8]   IDENTIFICATION OF PHOSPHATIDYLSERINE AND PHOSPHATIDYLCHOLINE IN CALCIUM-INDUCED PHASE SEPARATED DOMAINS [J].
HUI, SW ;
BONI, LT ;
STEWART, TP ;
ISAC, T .
BIOCHEMISTRY, 1983, 22 (14) :3511-3516
[9]   GADOLINIUM-LABELED LIPOSOMES - TARGETED MR CONTRAST AGENTS FOR THE LIVER AND SPLEEN [J].
KABALKA, G ;
BUONOCORE, E ;
HUBNER, K ;
MOSS, T ;
NORLEY, N ;
HUANG, L .
RADIOLOGY, 1987, 163 (01) :255-258
[10]  
KENNEL SJ, 1988, LAB INVEST, V59, P692